Istiratumab (Anti-HER3 & IGF-1R)
Istiratumab is a fully human tetravalent bispecific antibody that binds to and co-inhibits IGF-1R and the epidermal growth factor family of receptor tyrosine kinases B3 (ErbB3), with potential anti-tumor activity. MW: 199.64 KD.
Trivial name | MM-141 |
Catalog Number | A4013 |
CAS# | 1509928-04-4 |
Size | 1mg |
Supplier Page | http://www.selleckchem.com/products/istiratumab.html |